drugset / Trial / NCT00003647

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

Phase 3 Completed Vical
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the body build an immune response that will kill tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or without immunotherapy in treating patients who have stage III or stage IV melanoma.

Timeline

Start
1998-07
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Allovectin-7® Other / unclassified Other
Subject Dacarbazine Small molecule Intravenous

Indications